Title Iatrogenicity
Subtitle Causes and Consequences of Iatrogenesis in Cardiovascular Medicine
Author John Kostis, Ihor Gussak
ISBN 9780813590400
List price USD 99.95
Price outside India Available on Request
Original price
Binding Paperback
No of pages 304
Book size 153 x 229 mm
Publishing year 2018
Original publisher Rutgers University Press (Eurospan Group)
Published in India by .
Exclusive distributors Viva Books Private Limited
Sales territory India, Sri Lanka, Bangladesh, Pakistan, Nepal, .
Status New Arrival
About the book Send Enquiry
  
 

Description:

Iatrogenesis is the occurrence of untoward effects resulting from actions of health care providers, including medical errors, medical malpractice, practicing beyond one’s expertise, adverse effects of medication, unnecessary treatment, inappropriate screenings, and surgical errors. This is a huge public health issue: tens to hundreds of thousands of deaths are attributed to iatrogenic causes each year in the US, and vulnerable populations such as the elderly and minorities are particularly susceptible.

Edited by two renowned cardiology experts, Iatrogenicity: Causes and Consequences of Iatrogenesis in Cardiovascular Medicine addresses both the iatrogenicity that arises with cardiovascular interventions, as well as non-cardiovascular interventions that result in adverse consequences on the cardiovascular system. The book aims to achieve three things: to summarize the available information on this topic in a single high-yield volume; to highlight the human and financial cost of iatrogenesis; and to describe and propose potential interventions to ameliorate the effects of iatrogenesis. This accessible book is a practical reference for any practicing physician who sees patients with cardiovascular issues.

 

Contents:

Contributors

The Concept of latrogenicity
John B. Kostis and Ihor B. Gussak

PART I: Medical Harm
Ihor B. Gussak and William J. Kostis

Chapter 1: latrogenicity: Definition, History, and Modern Context
Maria L. Gussak, Ihor B. Gussak, and John B. Kostis

Chapter 2: Epidemiology and Public Health Aspects and Implications of latrogenicity: Regulatory, Legal and Ethical Dimensions
Miriam A. Gonzalez-Siegel and Stephen K. Jones

Chapter 3: Risk Management: The Medical Center Administration Perspective
Stephen K. Jones and Miriam A. Gonzalez-Siegel

Chapter 4: latrogenicity from the Patient’s Perspective
Jeanne M. Dobrrynski

Chapter 5: A Naturopathic Perspective on Iatrogenesis
Christie Fleetwood

PART II: latrogenicity of Cardiovascular Drugs and Cardiovascular Toxicity of Noncardiac Drugs
Arshad Jahangir and Gan-Xin Yan

Chapter 6: Clinical Manifestations of Acute and Chronic Drug-Induced Iatrogenic Cardiovascular Diseases and Syndromes
Ihor B. Gussak, Gan-Xin Yan, Arshad Jahangir, Georg Gussak, and John B. Kostis

Chapter 7: Drug-Induced Cardiac Arrhythmias and Sudden Cardiac Death
Aalap Narichania, Yasuhiro Yokoyama, and Win K. Shen

Chapter 8: Chemotherapy-Induced Cardiomyopathy
Edo Y. Birati and Mariell Jessup

Chapter 9: latrogenicity of Blood Pressure Measurement in the Diagnosis of Hypertension
Thomas D. Giles, Gary E. Sander, and Camilo Fernandez

Chapter 10: Antihypertensive Drug-Induced latrogenic Cardiovascular Syndromes
Rigas G. Kalaitzidis and George L. Bakris

Chapter 11: latrogenicity of Cardiovascular Drugs Associated With Cardiac and Noncardiac Toxicities: Antihypertensive Agents and Biologics
Evelyn R. Hermes-DeSantis and Joseph A. Barone

Chapter 12: latrogenic Aspects of Hypertension in Pregnancy: Focus on Preeclampsia
Costas Thomopoulos and Thomas Makris

Chapter 13: Women and latrogenic Cardiovascular Disease: Menopausal Estrogen as the Prime Suspect
Gloria Bachmann, Nancy Phillips, and Margaret Rees

Chapter 14: latrogenic Aspects of Lipid-Lowering, Antiplatelet, and Anticoagulant Agents
Konstantinos Tsioufis, Dimitris Konstantinidis, Nikolaos Vogiatzakis, Kyriakos Dimitriadis, and Dimitris Tonsoulis

Chapter 15: latrogenic Effects of Urologic Drugs on the Cardiovascular System
Konstantinos Stavropoulos, Chrysoula Boutari, Konstantinos Imprialos, Vasilios Papademetriou, and Michael Doumas

Chapter 16: latrogenicity and Antianginal Drugs
Abel E. Moreyra and William J. Kostis

Chapter 17: Antidiabetic Drugs and Cardiovascular Risk: Where Do We Stand?
Rajesh Kumar

Chapter 18: Cardiovascular latrogenicity in Older Adults
Ariba Khan, Fatima Ali, Vibha Iyengar, Yuya Hagiwara, VJ Periyakoil, Neela Patel, and Michael Malone

PART III: latrogenicity of Diagnostic and Therapeutic, Invasive and Noninvasive Cardiovascular Interventions, Devices, and Surgeries
Ibrahim Akin, Martin Borggrefe, and William J. Kostis

Chapter 19: latrogenic Aspects of Noninvasive and Invasive Diagnostic Methods in Interventional Cardiology
Christina Dosch, Dirk Eol nitzer, and Theano Papavassiliu

Chapter 20: latrogenicity Associated With Interventional Treatment Modalities in Cardiology
Naga Venkata Pothineni, Aatish Gary, Hakan Paydak, and Jawahar L. Mehta

Chapter 21: latrogenicity of Diagnostic and Therapeutic, Invasive and Noninvasive Cardiovascular Interventions, Devices, and Surgeries
Michael Behnes, Tobias Becher, Stefan Baumann, Uzair Ansari, and Ibrahim Akin

Chapter 22: latrogenic Aspects of Cardiac Electrophysiology
Boris Rudic, Erol Tulumen, Volker Liebe, and Martin Borggrefe

Chapter 23: latrogenic Aspects in Cardiac Device Therapy
Susanne Roger Niger and Jurgen Kuschyk

Chapter 24: Cardiovascular latrogenicity of Respiratory Therapeutic Modalities
Michael S. Nolledo, Pauline. Lerma, and Teodoro V. Santiago

PART IV: Iatrogenic Aspects of Sport Cardiology and Lifestyle Modifications
Giovanni Campanile, John B. Kostis, and Ihor B. Gussak

Chapter 25: Trained Athletes
Gino Seravalle, Guido Grassi, and Giuseppe Mancia

Chapter 26: Sports Cardiology
Giovanni Campanile

Chapter 27: Dangers of Lifestyle Modification Advice
Giovanni Campanile

PART V: latrogenicity of Dietary Supplements, Herbal Products, and Other Nontraditional Therapies in Cardiovascular Medicine
Arshad Jahangir, Ihor B. Gussak, and John B. Kostis

Chapter 28: Safety of Dietary and Herbal Supplements: Side Effects and Contraindications
Sulaiman Sultan, Ahad Jahangir, Ihor B. Gussak, A. Jamil Tajik, and Arshad Jahangir

Chapter 29: Interactions Between Supplements and Medications
Sulaiman Sultan, Ahad Jahangir, Ihor B. Gussak, John B. Kostis, A. Jamil Tajik, and Arshad Jahangir

Index

 

About the Editors:

IHOR GUSSAK, MD, PhD, FACC, is a clinical professor of medicine at the University of Medicine and Dentistry of New Jersey-Robert Wood Johnson, and executive editor of the Journal of Electrocardiology.

JOHN B. KOSTIS, MD, FACP, FACC, is the John G. Detwiler Professor of Cardiology, professor of medicine and pharmacology, and associate dean for cardiovascular research at the University of Medicine and Dentistry of New Jersey. He is also the director of the Cardiovascular Institute at Robert Wood Johnson Medical School in New Brunswick, New Jersey.


Target Audience:

This accessible book is a practical reference for any practicing physician who sees patients with cardiovascular issues.

 

 
Special prices are applicable to the authorised sales territory only.
Prices are subject to change without prior notice.